Cosmo Pharmaceuticals N.V. (ETR: C43)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,029	879	1,015	1,065	1,136	1,032
Market Cap Growth	55.18%	-13.35%	-4.77%	-6.21%	10.07%	-11.83%
Enterprise Value	899	838	974	1,028	1,067	868
Last Close Price	61.50	53.51	61.30	61.30	-	-
PE Ratio	14.79	-	58.91	49.16	-	-
PS Ratio	6.31	9.48	9.94	16.37	18.64	16.51
PB Ratio	2.31	2.05	2.19	2.08	2.84	2.62
P/TBV Ratio	11.69	20.67	14.08	9.52	2.87	2.78
P/FCF Ratio	10.25	29.04	35.34	149.55	128.14	-
P/OCF Ratio	9.96	26.15	30.54	84.48	87.48	-
EV/Sales Ratio	4.69	9.03	9.54	15.80	17.50	13.89
EV/EBITDA Ratio	8.65	42.51	23.65	57.74	176.12	-
EV/EBIT Ratio	10.12	136.27	34.71	92.64	590.89	-
EV/FCF Ratio	7.89	27.66	33.92	144.35	120.31	-
Debt / Equity Ratio	0.00	0.00	0.37	0.33	0.42	0.42
Debt / EBITDA Ratio	0.01	0.09	4.14	9.20	24.49	-
Debt / FCF Ratio	0.01	0.06	6.05	23.85	18.97	-
Asset Turnover	0.27	0.14	0.13	0.09	0.10	0.10
Inventory Turnover	3.19	3.06	3.29	3.50	4.66	4.97
Quick Ratio	4.35	3.15	1.45	11.77	11.06	18.39
Current Ratio	4.85	3.98	1.57	12.99	11.60	19.25
Return on Equity (ROE)	14.80%	-1.06%	3.59%	4.75%	-1.99%	-5.84%
Return on Assets (ROA)	7.82%	0.58%	2.24%	0.99%	0.19%	-1.27%
Return on Capital (ROIC)	9.59%	0.72%	2.66%	1.11%	0.20%	-1.32%
Earnings Yield	7.02%	-0.56%	1.70%	2.03%	-0.70%	-2.37%
FCF Yield	9.75%	3.44%	2.83%	0.67%	0.78%	-2.04%
Dividend Yield	2.82%	3.74%	1.71%	1.55%	-	-
Payout Ratio	6.07%	-	90.61%	-	-	-
Buyback Yield / Dilution	0.77%	1.95%	2.83%	-16.81%	1.11%	2.48%
Total Shareholder Return	0.77%	5.69%	4.54%	-15.26%	1.11%	2.48%

Source: S&P Capital IQ. Standard template. Financial Sources.